Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04382664
Title UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ultimovacs ASA
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | BEL


No variant requirements are available.